Collector
Giriş Yap
Lilly's Weight Loss Sets High Bar for Obesity Drug Race | Collector
Lilly's Weight Loss Sets High Bar for Obesity Drug Race

Lilly's Weight Loss Sets High Bar for Obesity Drug Race

Sam Fazeli, Director of Research for Global Industries and Senior Pharmaceuticals Analyst for Bloomberg Intelligence, joined Bloomberg's Scarlett Fu and Paul Sweeney to discuss the gains and losses in the GLP1 market. (Source: Bloomberg)

Go to News Site